Concentric Capital Strategies’s Abbott ABT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-1,727
Closed -$231K 251
2025
Q3
$231K Sell
1,727
-10
-0.6% -$1.31K 0.01% 291
2025
Q2
$236K Buy
+1,737
New +$229K 0.01% 259
2024
Q4
Sell
-7,926
Closed -$904K 249
2024
Q3
$904K Buy
7,926
+4,884
+161% +$536K 0.04% 248
2024
Q2
$316K Buy
+3,042
New +$323K 0.02% 284
2023
Q4
Sell
-15,985
Closed -$1.55M 216
2023
Q3
$1.55M Buy
+15,985
New +$1.68M 0.16% 118
2023
Q2
Sell
-7,309
Closed -$740K 145
2023
Q1
$740K Buy
+7,309
New +$772K 0.24% 98

Other funds holding ABT

Concentric Capital Strategies's ABT Position: Q4 2025 in Review

Concentric Capital Strategies sold out of Abbott (ABT) in Q4 2025, closing a stake of 1,727 shares — an estimated $231K sold.

Concentric Capital Strategies first reported a position in ABT in Q1 2023 and held it in 6 quarters. The position peaked at $1.55M in Q3 2023. 3,284 funds tracked by Wall St. Rank hold ABT as of Q4 2025.

  • Concentric Capital Strategies reported no remaining Abbott position as of Q4 2025 after selling out during the quarter.
  • Concentric Capital Strategies sold 1,727 Abbott shares in Q4 2025, an estimated $231K.
  • Concentric Capital Strategies first reported a position in Abbott in Q1 2023 and held it in 6 quarters.
  • Concentric Capital Strategies's Abbott position peaked at $1.55M in Q3 2023.
  • 3,284 funds tracked by Wall St. Rank held Abbott as of Q4 2025.

Based on Concentric Capital Strategies's 13F filing for Q4 2025, filed 17 Feb 2026.